Skip to main content
. 2020 May 11;22:32. doi: 10.1186/s12968-020-00609-z

Table 2.

CMR Examination Data

All patients (n = 208) Primary prevention (n = 115) Secondary prevention (n = 93) p–value
Heart rate, bpm 68 ± 14 70 ± 14 64 ± 13 0.002
Systolic BP, mmHg 127 ± 20 124 ± 20 130 ± 21 0.010
Diastolic BP, mmHg 73 ± 12 73 ± 12 74 ± 12 0.888
LVEDV, ml 249 ± 106 283 ± 111 207 ± 83 < 0.001
LVESV, ml 170 ± 102 207 ± 104 125 ± 78 < 0.001
LVEF, % 36 ± 15 30 ± 13 44 ± 13 < 0.001
RVEDV, ml 128 ± 65 133 ± 71 121 ± 55 0.163
RVESV, ml 62 ± 48 66 ± 53 57 ± 40 0.139
RVEF, % 54 ± 11 54 ± 12 56 ± 10 0.186
LGE positive (n = 206), n(%) 135 (66) 73 (65) 62 (67) 0.756
LV, LGE positive, n(%) 132 (64) 73 (65) 59 (63) 0.863
LV-LGE pattern (n = 132) 0.862
 subendocardial, n(%) 82 (62) 47 (64) 35 (59)
 subepicardial, n(%) 14 (11) 7 (10) 7 (12)
 midwall striae, n(%) 23 (17) 13 (18) 10 (17)
 midwall patchy, n(%) 13 (10) 6 (8) 7 (12)
LV-LGE, segments 4.1 ± 2.7 4.2 ± 2.8 4.0 ± 2.5 0.647
LV-LGE, % transmurality 73 ± 25 75 ± 24 70 ± 26 0.243
RV, LGE positive, n(%) 9 (4) 2 (2) 7 (8) 0.044
LV thrombus, n(%) 9 (4) 5 (4) 4 (4) 0.987

Values are mean ± SD or n (%); p-values are given for the comparison of primary versus secondary prevention. BP blood pressure; LVEDV left ventricular end–diastolic volume; LVESV left ventricular end–systolic volume; LVEF left ventricular ejection fraction; LGE late gadolinium enhancement; RV right ventricle; LV LGE pattern was categorized according to reference [11]